Press Releases

13 May '21
IMAC Holdings Reports First Quarter 2021 Financial Results and Corporate Update
PDF Version
BRENTWOOD, Tenn. , May 13, 2021 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC ) (“IMAC” or the “Company”), a provider of innovative medical advancements and care specializing in regenerative rehabilitation orthopedic treatments without the use of surgery or opioids, today announced
26 Apr '21
IMAC Holdings CEO Jeff Ervin Provides Corporate Update in Letter to Shareholders
PDF Version
Brentwood, Tenn. , April 26, 2021 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC , IMACW), a provider of innovative medical advancements and care specializing in regenerative and rehabilitative orthopedic treatments without the use of surgery or opioids, today issued a corporate update in a
23 Mar '21
IMAC Holdings Announces Pricing of its Public Offering of Common Stock
PDF Version
Brentwood, Tenn , March 23, 2021 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (the “Company” or “IMAC”) (Nasdaq: IMAC , IMACW), a provider of innovative medical advancements and care specializing in regenerative and rehabilitation orthopedic treatments without the use of surgery or opioids, announced
04 Mar '21
IMAC Holdings Reports 2020 Financial Results and Corporate Update
PDF Version
BRENTWOOD, Tenn. , March 04, 2021 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC ) (“IMAC” or the “Company”), a provider of innovative medical advancements and care specializing in regenerative rehabilitation orthopedic treatments without the use of surgery or opioids, today announced
01 Mar '21
IMAC Holdings, Inc. Announces Completion of First Cohort of its Phase 1 Clinical Study of Umbilical Cord-Derived Mesenchymal Stem Cells for the Treatment of Bradykinesia Due to Parkinson’s Disease
PDF Version
BRENTWOOD, Tenn , March 01, 2021 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC ) (“IMAC” or “the Company”), today announces it has completed the first cohort of its Phase 1 clinical trial for its investigational compound utilizing umbilical cord-derived allogenic mesenchymal stem cells for
25 Feb '21
IMAC Partners with Fortune 500 Company to Launch In-Store Spinal Care
PDF Version
  The Back Space will deliver chiropractic and spinal care services in a multi-store test market BRENTWOOD, Tenn. , Feb. 25, 2021 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC ), today announced a strategic partnership with a Fortune 500 company by launching its new wholly-owned subsidiary
Displaying 11 - 20 of 26